Table 4.

Effects of PF4 on Apoptosis Induced by TGFβ1, 5-FU, or ETP in CD34+ CB Cells

PF4 ( μg/mL)TGFβ1 (1 ng/mL)5-FU (2.5 μg/mL)Etoposide (1 μg/mL)
Viability (%)Apoptotic Cells (%)Viability (%)Apoptotic Cells (%)Viability (%)Apoptotic Cells (%)
72 ± 6 10 ± 3 45 ± 3 17 ± 2 41 ± 3 21 ± 3 
91 ± 34-150 2 ± 14-150 87 ± 64-150 3 ± 24-150 79 ± 64-150 4 ± 14-150 
PF4 ( μg/mL)TGFβ1 (1 ng/mL)5-FU (2.5 μg/mL)Etoposide (1 μg/mL)
Viability (%)Apoptotic Cells (%)Viability (%)Apoptotic Cells (%)Viability (%)Apoptotic Cells (%)
72 ± 6 10 ± 3 45 ± 3 17 ± 2 41 ± 3 21 ± 3 
91 ± 34-150 2 ± 14-150 87 ± 64-150 3 ± 24-150 79 ± 64-150 4 ± 14-150 

CD34+ CB cells at 104/mL were first incubated in liquid culture in the presence or absence of PF4 5 μg/mL for 2 days. TGFβ1, 5-FU, or ETP were separately added to the culture for an additional incubation for 24 hours. Results are expressed as the mean ± SEM of triplicate determinations.

F4-150

P < .05 v control cells without PF4 treatment.

or Create an Account

Close Modal
Close Modal